Phase I/II Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Trial Profile

Phase I/II Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 07 Jun 2017

At a glance

  • Drugs YS 110 (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Kissei Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top